William Blair & Company’s Theriva Biologics TOVX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-406
| Closed | -$2.4K | – | 1874 |
|
|
2024
Q2 | $2.4K | Hold |
406
| – | – | ﹤0.01% | 1796 |
|
|
2024
Q1 | $4.76K | Hold |
406
| – | – | ﹤0.01% | 1749 |
|
|
2023
Q4 | $4.37K | Buy |
+406
| New | +$4.37K | ﹤0.01% | 1742 |
|
|
2022
Q4 | – | Sell |
-1,268
| Closed | -$31K | – | 1878 |
|
|
2022
Q3 | $31K | Buy |
1,268
+55
| +5% | +$1.35K | ﹤0.01% | 1653 |
|
|
2022
Q2 | $65K | Buy |
1,213
+183
| +18% | +$9.81K | ﹤0.01% | 1596 |
|
|
2022
Q1 | $73K | Buy |
1,030
+166
| +19% | +$11.8K | ﹤0.01% | 1663 |
|
|
2021
Q4 | $59K | Buy |
864
+49
| +6% | +$3.35K | ﹤0.01% | 1758 |
|
|
2021
Q3 | $94K | Buy |
815
+130
| +19% | +$15K | ﹤0.01% | 1619 |
|
|
2021
Q2 | $103K | Buy |
685
+402
| +142% | +$60.4K | ﹤0.01% | 1608 |
|
|
2021
Q1 | $48K | Buy |
283
+65
| +30% | +$11K | ﹤0.01% | 1673 |
|
|
2020
Q4 | $21K | Buy |
218
+7
| +3% | +$674 | ﹤0.01% | 1698 |
|
|
2020
Q3 | $25K | Sell |
211
-33
| -14% | -$3.91K | ﹤0.01% | 1566 |
|
|
2020
Q2 | $31K | Buy |
244
+26
| +12% | +$3.3K | ﹤0.01% | 1495 |
|
|
2020
Q1 | $18K | Buy |
218
+13
| +6% | +$1.07K | ﹤0.01% | 1505 |
|
|
2019
Q4 | $26K | Sell |
205
-7
| -3% | -$888 | ﹤0.01% | 1550 |
|
|
2019
Q3 | $24K | Sell |
212
-4
| -2% | -$453 | ﹤0.01% | 1525 |
|
|
2019
Q2 | $30K | Sell |
216
-10
| -4% | -$1.39K | ﹤0.01% | 1549 |
|
|
2019
Q1 | $38K | Buy |
226
+48
| +27% | +$8.07K | ﹤0.01% | 1501 |
|
|
2018
Q4 | $25K | Buy |
+178
| New | +$25K | ﹤0.01% | 1458 |
|
|
2018
Q3 | – | Sell |
-253
| Closed | -$529K | – | 1654 |
|
|
2018
Q2 | $529K | Buy |
253
+27
| +12% | +$56.5K | ﹤0.01% | 928 |
|
|
2018
Q1 | $631K | Buy |
226
+29
| +15% | +$81K | ﹤0.01% | 846 |
|
|
2017
Q4 | $877K | Buy |
+197
| New | +$877K | 0.01% | 778 |
|
|
2017
Q3 | – | Sell |
-183
| Closed | -$906K | – | 1403 |
|
|
2017
Q2 | $906K | Sell |
183
-4
| -2% | -$19.8K | 0.01% | 780 |
|
|
2017
Q1 | $1.29M | Sell |
187
-1
| -0.5% | -$6.92K | 0.01% | 640 |
|
|
2016
Q4 | $1.26M | Sell |
188
-40
| -18% | -$267K | 0.01% | 600 |
|
|
2016
Q3 | $3.44M | Sell |
228
-12
| -5% | -$181K | 0.03% | 378 |
|
|
2016
Q2 | $3.78M | Sell |
240
-57
| -19% | -$898K | 0.04% | 339 |
|
|
2016
Q1 | $6.13M | Buy |
297
+32
| +12% | +$660K | 0.06% | 262 |
|
|
2015
Q4 | $5.31M | Buy |
265
+59
| +29% | +$1.18M | 0.05% | 281 |
|
|
2015
Q3 | $4.1M | Buy |
206
+82
| +66% | +$1.63M | 0.04% | 358 |
|
|
2015
Q2 | $3.1M | Buy |
+124
| New | +$3.1M | ﹤0.01% | 1198 |
|